Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Pathogens inactivated by low-energy-electron irradiation maintain antigenic properties and induce protective immune responses

: Fertey, Jasmin; Bayer, Lea; Grunwald, Thomas; Pohl, Alexandra; Beckmann, Jana; Gotzmann, Gaby; Portillo Casado, Javier; Schönfelder, Jessy; Rögner, Frank-Holm; Wetzel, Christiane; Thoma, Martin; Bailer, Susanne M.; Hiller, Ekkehard; Rupp, Steffen; Ulbert, Sebastian

Volltext urn:nbn:de:0011-n-4232736 (1.1 MByte PDF)
MD5 Fingerprint: fac75e26e3d2f1ce0b158513a8e4ce1e
(CC) by
Erstellt am: 25.11.2016

Viruses 8 (2016), Nr.11, Art. 319, 14 S.
ISSN: 1999-4915
Zeitschriftenaufsatz, Elektronische Publikation
Fraunhofer FEP ()
Fraunhofer IZI ()
Fraunhofer IGB ()
Fraunhofer IPA ()
pathogen inactivation; low-energy electron irradiation; vaccines; influenza A; Impfstoff; Medizin; Niederspannung; Elektron; Immunsystem; Erreger

Inactivated vaccines are commonly produced by incubating pathogens with chemicals such as formaldehyde or β-propiolactone. This is a time-consuming process, the inactivation efficiency displays high variability and extensive downstream procedures are often required. Moreover, application of chemicals alters the antigenic components of the viruses or bacteria, resulting in reduced antibody specificity and therefore stimulation of a less effective immune response. An alternative method for inactivation of pathogens is ionizing radiation. It acts very fast and predominantly damages nucleic acids, conserving most of the antigenic structures. However, currently used irradiation technologies (mostly gamma-rays and high energy electrons) require large and complex shielding constructions to protect the environment from radioactivity or X-rays generated during the process. This excludes them from direct integration into biological production facilities. Here, low-energy electron irradiation (LEEI) is presented as an alternative inactivation method for pathogens in liquid solutions. LEEI can be used in normal laboratories, including good manufacturing practice (GMP)- or high biosafety level (BSL)-environments, as only minor shielding is necessary. We show that LEEI efficiently inactivates different viruses (influenza A (H3N8), porcine reproductive and respiratory syndrome virus (PRRSV), equine herpesvirus 1 (EHV-1)) and bacteria (Escherichia coli) and maintains their antigenicity. Moreover, LEEI-inactivated influenza A viruses elicit protective immune responses in animals, as analyzed by virus neutralization assays and viral load determination upon challenge. These results have implications for novel ways of developing and manufacturing inactivated vaccines with improved efficacy.